II. Mechanism: Ergosterol
- Most Antifungal agents selectively target Ergosterol
- Ergosterol is the key sterol in fungal cell membranes
- Ergosterol is a target of many Antifungal agents
- Antifungals bind, disrupt or interfering with ergosterol synthesis
- As with other organisms, sterols are a key component of the cell wall
- Contrast with Cholesterol cell walls in humans and hopanoids in Bacteria
III. Medications: Azoles
- Background
- Azoles inhibit the synthesis of ergosterol (key component of fungal cell wall)
- Azoles block sterol 14-a-dimethylase (microsomal Cytochrome P450-dependent enzyme)
- 14-a-dimethylase converts lanosterol to ergosterol
- Blocking 14-a-dimethylase, results in ergosterol depletion
- Ergosterol depletion results in disruption of fungal cell wall
- Imidazoles (primarily used topically for candida and dermatophyte infections)
- Clotrimazole
- Miconazole
- Ketoconazole
- Broad spectrum coverage and has been used systemically
- However is largely replaced for systemic use by newer, less-toxic triazoles
- Triazoles (primarily used orally for systemic Fungal Infections)
- Adverse Effects (when used systemically, see specific agents)
- Gastrointestinal (e.g. Nausea, Vomiting, Anorexia) - common
- Adrenal Suppression
- Hepatotoxicity
- Transient rise in Liver Function Tests is common
- Regularly monitor for more serious hepatotoxicity
IV. Medications: Allylamine
- Background
- Indicated in superficial dermatophyte infections resistant to imidazoles
- Allylamines block Ergosterol synthesis (key component in the fungal cell wall)
- Inhibit squalene epoxidase, the enzyme that converts squalene to ergosterol
- Medications
- Naftifine (Naftin, topical)
- Terbinafine (Lamisil)
- Topical for resistant dermatophyte infections
- Accumulates in nails
- Oral Terbinafine is the preferred agent for Onychomycosis
V. Medications: Polyene
- Background
- Polyenes bind to ergosterol within the fungal cell membrane
- Results in fungal cell Membrane Depolarization and increased permeability
- Fungal cell leaks key intracellular components, and ruptures
- Polyenes bind to ergosterol within the fungal cell membrane
-
Amphotericin B
- Preferred agent for deep Fungal Infections in pregnancy (long safety data record)
- Covers most medically important fungi, but with serious adverse effects (esp. nephrotoxicity)
- Poor oral Bioavailability, and used primarily IV (also used intrathecally and as a Bladder wash)
- Systemic, invasive, life-threatening Fungal Infections (including Meningitis, cystitis) and some Protozoa infections
- Largely replaced by newer, less toxic fungicides
- Candidemia
- Symptomatic candida cystitis or Pyelonephritis
- Cryptococcal Meningitis (HIV Infection, administered with Flucytosine)
-
Nystatin
- Used only topically (e.g. Diaper Candidiasis) or on mucosa (e.g. Thrush)
- Too systemically toxic to be used IV
- Not absorbed from the Gastrointestinal Tract
-
Cutaneous Candidiasis (topical Nystatin)
- Candida Diaper Dermatitis
- Candidal Intertrigo
-
Oral Candidiasis (Thrush)
- First-line agent
- Used only topically (e.g. Diaper Candidiasis) or on mucosa (e.g. Thrush)
VI. Medications: Echinocandin (Glucan Synthesis Inhibitor)
- Background
- Echinocandins (Cyclic Lipopeptides) inhibit synthesis of beta-(1,3)-D-Glucan a key cell wall component
- Active against Candida species (including those resistant to Azole Antifungals) and some Aspergillus species
- Medications
- Caspofungin
- Micafungin
- Andulafungin
VII. Medications: Miscellaneous
-
Flucytosine (categorized as an antimetabolite)
- Flucytosine is a Fluorouracil prodrug, a fluorinated cytosine analog with Antifungal activity
- Within fungal cells, Flucytosine is deaminated to the active metabolite 5-Fluorouracil
- 5-Fluorouracil substitutes for the Pyrimidine uracil during RNA synthesis
- Inhibits fungal Protein synthesis
- Indications: Systemic Fungal Infections
- Used primarily with Amphotericin B (risk of induced resistance when used alone)
- Cryptococcal Meningitis
- CNS Candidiasis (HIV Infection)
- Candida Pyelonephritis
-
Griseofulvin (categorized as a Benzofuran)
- Antifungal derived first in 1958 from the mold Penicillium griseofulvum
- Indications limited to Tinea Capitis as an alternative agent
- Inhibits fungal cell division by inhibiting microtubule function in Mitosis
- Binds tubulin in fungi and disrupts mitotic spindles
-
Saturated Solution Potassium iodide (SSKI)
- Used to treat Sporotrichosis in under-resourced regions of the world
VIII. References
- (2012) Med Lett Drugs Ther 10(120): 61-8
- Gladwin, Trattler and Mahan (2014) Clinical Microbiology, Medmaster, Fl
Images: Related links to external sites (from Bing)
Related Studies
antifungal (on 8/23/2023 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
ANTIFUNGAL 1% CREAM | Generic OTC | $0.10 per gram |
ANTIFUNGAL 1% TOPICAL CREAM | Generic OTC | $0.16 per gram |
ANTIFUNGAL 2% POWDER | Generic OTC | $0.05 per gram |